These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11900516)

  • 41. Isolated elevation of alkaline phosphatase level associated with rosiglitazone.
    Hachey DM; O'Neil MP; Force RW
    Ann Intern Med; 2000 Nov; 133(9):752. PubMed ID: 11074926
    [No Abstract]   [Full Text] [Related]  

  • 42. Rosiglitazone (Avandia): hepatic, cardiac and hematological reactions.
    McMorran M; Vu D
    CMAJ; 2001 Jul; 165(1):82-3, 86-7. PubMed ID: 11468963
    [No Abstract]   [Full Text] [Related]  

  • 43. [A new case: pioglitazone hepatotoxicity].
    Martínez Odriozola P; Ibarmia Lahuerta J; Gutiérrez Macías A; de la Villa FM
    Med Clin (Barc); 2007 Jun; 129(4):158-9. PubMed ID: 17663974
    [No Abstract]   [Full Text] [Related]  

  • 44. Fatal toxic intrahepatic cholestasis secondary to glibenclamide.
    Krivoy N; Zaher A; Yaacov B; Alroy G
    Diabetes Care; 1996 Apr; 19(4):385-6. PubMed ID: 8729168
    [No Abstract]   [Full Text] [Related]  

  • 45. Troglitazone-associated hepatic failure.
    Misbin RI
    Ann Intern Med; 1999 Feb; 130(4 Pt 1):330. PubMed ID: 10068399
    [No Abstract]   [Full Text] [Related]  

  • 46. [Pioglitazone-induced acute severe hepatitis].
    Arotçarena R; Bigué JP; Etcharry F; Pariente A
    Gastroenterol Clin Biol; 2004; 28(6-7 Pt 1):610-1. PubMed ID: 15243398
    [No Abstract]   [Full Text] [Related]  

  • 47. Liver failure in a patient treated with long-term rosiglitazone therapy.
    Gouda HE; Khan A; Schwartz J; Cohen RI
    Am J Med; 2001 Nov; 111(7):584-5. PubMed ID: 11705443
    [No Abstract]   [Full Text] [Related]  

  • 48. Company played down drug's risks, report says.
    Gottlieb S
    BMJ; 2001 Mar; 322(7288):696. PubMed ID: 11264205
    [No Abstract]   [Full Text] [Related]  

  • 49. Rules and laws of drug hepatotoxicity.
    Kaplowitz N
    Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):231-3. PubMed ID: 16552791
    [No Abstract]   [Full Text] [Related]  

  • 50. An autopsy case of troglitazone-induced fulminant hepatitis.
    Shibuya A; Watanabe M; Fujita Y; Saigenji K; Kuwao S; Takahashi H; Takeuchi H
    Diabetes Care; 1998 Dec; 21(12):2140-3. PubMed ID: 9839107
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Thiazolidinediones].
    Scheen AJ; Paquot N; Letiexhe MR; Lefèbvre PJ
    Journ Annu Diabetol Hotel Dieu; 1999; ():213-29. PubMed ID: 10732419
    [No Abstract]   [Full Text] [Related]  

  • 52. Rosiglitazone-induced granulomatous hepatitis.
    Dhawan M; Agrawal R; Ravi J; Gulati S; Silverman J; Nathan G; Raab S; Brodmerkel G
    J Clin Gastroenterol; 2002; 34(5):582-4. PubMed ID: 11960075
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical effect and side effect of troglitazone].
    Toyota T; Ueno Y
    Nihon Rinsho; 2000 Feb; 58(2):376-82. PubMed ID: 10707561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Severe electrolyte imbalance and edema in therapy with rosiglitazone].
    Kuschel U; Hesselbarth N; Herrmann A; Hippius M; Hoffmann A
    Med Klin (Munich); 2002 Sep; 97(9):553-5. PubMed ID: 12371084
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The development of thiazolidinedione drugs as anti-diabetic agents].
    Kuzuya T
    Nihon Rinsho; 2000 Feb; 58(2):364-9. PubMed ID: 10707559
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical efficacy of Pioglitazone (AD-4833)].
    Kaneko T; Baba S
    Nihon Rinsho; 1997 Nov; 55 Suppl():142-6. PubMed ID: 9434458
    [No Abstract]   [Full Text] [Related]  

  • 57. [Cholestasis in imipenem/cilastatin treatment].
    Schreiber C; May B
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():76-7. PubMed ID: 7483723
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Case series of liver failure associated with rosiglitazone and pioglitazone.
    Floyd JS; Barbehenn E; Lurie P; Wolfe SM
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1238-43. PubMed ID: 19623674
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Evaluation of thiazolidinedione derivative drugs for safety].
    Kobayashi M; Iwata M
    Nihon Rinsho; 2001 Nov; 59(11):2228-32. PubMed ID: 11712412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diabetes drug Rezulin: take it, but take precautions.
    Health News; 1999 May; 5(6):7. PubMed ID: 10546576
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.